Navidea Biopharmaceuticals, Inc.
NAVB
$0.0001
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -37.10% | 18,077.22% | -98.31% | -56.62% | 1,302.68% |
| Total Receivables | -30.87% | 44.19% | 5,066.67% | -99.61% | 415.61% |
| Inventory | 0.00% | 0.02% | 7.79% | 120.49% | -38.61% |
| Prepaid Expenses | -58.73% | -47.15% | -13.84% | 419.72% | -69.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -35.71% | 484.93% | -62.62% | -37.18% | 335.63% |
|
|
|||||
| Total Current Assets | -35.71% | 484.93% | -62.62% | -37.18% | 335.63% |
| Net Property, Plant & Equipment | -15.92% | -3.86% | -5.08% | -16.12% | -13.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.29% | 5.04% | 1.04% | 6.27% | 5.68% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -62.89% | -86.00% |
| Total Assets | -30.67% | 247.18% | -45.84% | -30.15% | 149.97% |
|
|
|||||
| Total Accounts Payable | 3.13% | -36.68% | 49.40% | 22.09% | -28.36% |
| Total Accrued Expenses | -8.99% | -13.79% | -33.13% | 27.34% | 195.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.87% | 278.64% | -37.18% | 1,960.81% | -76.94% |
| Total Finance Division Other Current Liabilities | 1.86% | -12.09% | 75.79% | -49.83% | 50.56% |
| Total Other Current Liabilities | 1.86% | -12.09% | 75.79% | -49.83% | 50.56% |
| Total Current Liabilities | -3.94% | -10.21% | -6.96% | 17.89% | 58.45% |
|
|
|||||
| Total Current Liabilities | -3.94% | -10.21% | -6.96% | 17.89% | 58.45% |
| Long-Term Debt | -- | -- | 4.93% | 4.51% | 148.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -40.00% | -44.44% | -30.77% | -23.53% | -19.05% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -3.64% | -24.41% | -4.79% | 14.55% | 61.99% |
|
|
|||||
| Common Stock & APIC | 0.02% | 0.77% | 0.02% | 0.00% | 1.97% |
| Retained Earnings | -0.59% | 1.50% | -0.38% | -0.91% | -2.06% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -203.24% | 89.03% | -16.65% | -70.09% | -9.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -100.00% | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -203.24% | 89.03% | -16.65% | -70.09% | -9.41% |
| Total Preferred Equity | -100.00% | -- | -- | -- | -- |
| Total Minority Interest | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Equity | -278.85% | 91.76% | -17.24% | -74.48% | -10.06% |
|
|
|||||
